Dr. Mahalaxmi Andheria brings with her an experience of more than 15 years in the Pharma & Biotech Industry. She has been actively involved in Formulation R&D for 5 years before she decided to switch to IPR and thereafter IPR has been her primary area of focus. Dr. Andheria is a PhD in Pharmaceutics from ICT (former UDCT, Mumbai) and a post-doctorate from University of Cincinnati, USA.
In her present association with Panacea Biotec since the last 10 years, she has been instrumental in managing the IPR Department consisting of specialists in diverse fields including biological (vaccines and biosimilars), pharmaceutical & synthetic chemistry area. She has established a seamless collaboration with Business Development and R&D expanding the horizon of her department beyond traditional IPR, broadening the outlook into portfolio planning, strategizing innovation and through creative participation in collaborations.
In addition Dr. Andheria actively engages in dialogue with policy makers in an effort to contribute towards the development of a robust and balanced National IP Policy in India.